Orphan and Ultra-Orphan Technologies European and Australian Payer Perceptions (Meeting Abstract
Payers are seeking more value-based information to better inform decision making in the evaluation of new orphan and ultra-orphan technologies. The challenge lies with the value of the new technology and who is judging that value. Rising costs of orphan and ultra-orphan technologies will have more impact on market access in the future, with increasing resistance to high prices.
Hogue, S., Brogan, A., & Croft, E. (2015). Orphan and Ultra-Orphan Technologies: European and Australian Payer Perceptions (Meeting Abstract. Value in Health, 18(7), A681. DOI: 10.1016/j.jval.2015.09.2027